Express Scripts (ESRX) Stake Increased by Great West Life Assurance Co. Can

Great West Life Assurance Co. Can boosted its stake in shares of Express Scripts (NASDAQ:ESRX) by 8.4% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,577,528 shares of the company’s stock after buying an additional 122,015 shares during the quarter. Great West Life Assurance Co. Can owned approximately 0.28% of Express Scripts worth $109,065,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. SeaCrest Wealth Management LLC bought a new position in Express Scripts during the fourth quarter valued at about $105,000. Aevitas Wealth Management Inc. bought a new position in Express Scripts during the fourth quarter valued at about $128,000. Financial Gravity Companies Inc. bought a new position in Express Scripts during the fourth quarter valued at about $142,000. ClariVest Asset Management LLC grew its position in Express Scripts by 31,700.0% during the first quarter. ClariVest Asset Management LLC now owns 2,226 shares of the company’s stock valued at $153,000 after buying an additional 2,219 shares during the period. Finally, Virtue Capital Management LLC bought a new position in Express Scripts during the fourth quarter valued at about $176,000. Institutional investors own 85.82% of the company’s stock.

In other news, VP Everett Neville sold 4,895 shares of the stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $75.26, for a total value of $368,397.70. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Christine Houston sold 19,889 shares of the stock in a transaction dated Thursday, March 15th. The stock was sold at an average price of $76.69, for a total transaction of $1,525,287.41. The disclosure for this sale can be found here. Corporate insiders own 0.79% of the company’s stock.

Several equities analysts recently weighed in on ESRX shares. Zacks Investment Research lowered shares of Express Scripts from a “buy” rating to a “hold” rating in a research report on Friday, March 2nd. Sanford C. Bernstein downgraded shares of Express Scripts from a “market perform” rating to an “underperform” rating and upped their price objective for the company from $55.80 to $77.50 in a report on Tuesday, January 30th. BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Friday, February 23rd. Jefferies Group set a $91.00 price objective on shares of Express Scripts and gave the company a “buy” rating in a report on Wednesday, February 28th. Finally, Bank of America assumed coverage on shares of Express Scripts in a report on Tuesday, February 27th. They set an “underperform” rating and a $77.00 price objective on the stock. Four equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and six have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $82.50.

Shares of Express Scripts opened at $77.08 on Friday, Marketbeat Ratings reports. Express Scripts has a 12-month low of $55.80 and a 12-month high of $85.07. The stock has a market capitalization of $43.14 billion, a PE ratio of 10.16, a PEG ratio of 0.97 and a beta of 0.98. The company has a current ratio of 0.69, a quick ratio of 0.56 and a debt-to-equity ratio of 0.81.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Wednesday, May 2nd. The company reported $1.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.76 by $0.01. Express Scripts had a net margin of 4.59% and a return on equity of 25.41%. The firm had revenue of $24.77 billion for the quarter, compared to the consensus estimate of $24.80 billion. During the same period in the prior year, the firm posted $1.33 earnings per share. The company’s revenue for the quarter was up .5% on a year-over-year basis. analysts anticipate that Express Scripts will post 9.07 earnings per share for the current year.

Express Scripts Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply